Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.36 |
| ▸ | TSHR | P16473 | 2/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL419791 | 0.88 | — | — | |
| SCHEMBL3923279 | 0.88 | ALDH1A1 (0.40) | ALDH1A1TSHRTDP1 | |
| SCHEMBL3186347 | 0.84 | TSHR (0.38) | TSHRTDP1 | |
| SCHEMBL9737323 | 0.82 | ALDH1A1 (0.44) | ALDH1A1TSHR | |
| SCHEMBL11449186 | 0.80 | ALDH1A1 (0.35) | ALDH1A1TSHRTDP1 | |
| SCHEMBL8672445 | 0.78 | ALDH1A1 (0.33) | ALDH1A1TSHRTDP1 | |
| SCHEMBL4966512 | 0.78 | — | — | |
| SCHEMBL2782256 | 0.78 | — | — | |
| SCHEMBL40105 | 0.77 | TSHR (0.33) | ALDH1A1TSHRTDP1 | |
| SCHEMBL663289 | 0.76 | ALDH1A1 (0.32) | ALDH1A1TSHRTDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8426617-B2 | Asymmetric hydrogenation of alkenes using chiral iridium complexes | DSM IP ASSETS B.V. (NL) | 2013-04-23 | — | — | US | claimed |
| WO-2025090587-A1 | CANNABINOIDS COMPOUNDS AND THEIR USE IN THE TREATMENT OF NEURONAL DISORDERS | INMED PHARMACEUTICALS INC. (CA) | 2025-05-01 | — | — | WO | disclosed |
| WO-2025090133-A1 | COMPOSITIONS AND METHODS FOR USE OF CANNABINOL COMPOUNDS IN NEUROPROTECTION | INMED PHARMACEUTICALS INC. (CA) | 2025-05-01 | — | — | WO | disclosed |
| EP-3684353-A1 | TOPICAL FORMULATIONS OF CANNABINOIDS AND USE THEREOF IN THE TREATMENT OF PAIN | Inmed Pharmaceuticals Inc. (CA) | 2020-07-29 | — | — | EP | disclosed |
| WO-2019056123-A1 | TOPICAL FORMULATIONS OF CANNABINOIDS AND USE THEREOF IN THE TREATMENT OF PAIN | INMED PHARMACEUTICALS INC. (CA) | 2019-03-28 | — | — | WO | disclosed |
| EP-3452036-A1 | USE OF TOPICAL FORMULATIONS OF CANNABINOIDS IN THE TREATMENT OF EPIDERMOLYSIS BULLOSA AND RELATED CONNECTIVE TISSUE DISORDERS | Inmed Pharmaceuticals Inc. (CA) | 2019-03-13 | — | — | EP | disclosed |
| WO-2017190249-A1 | USE OF TOPICAL FORMULATIONS OF CANNABINOIDS IN THE TREATMENT OF EPIDERMOLYSIS BULLOSA AND RELATED CONNECTIVE TISSUE DISORDERS | INMED PHARMACEUTICALS INC. (CA) | 2017-11-09 | — | — | WO | disclosed |
| US-20080200732-A1 | Novel Intermediates Useful for the Preparation of Coenzymes, Process for the Preparation of Novel Intermediates and an Improved Process for the Preparation of Coenzymes | NICHOLAS PIRAMAL INDIA LIMITED (IN) | 2008-08-21 | — | — | US | disclosed |
| EP-1910263-A2 | NOVEL INTERMEDIATES USEFUL FOR THE PREPARATION OF COENZYMES, PROCESS FOR THE PREPARATION OF NOVEL INTERMEDIATES AND AN IMPROVED PROCESS FOR THE PREPARATION OF COENZYMES | Nicholas Piramal India Limited (IN) | 2008-04-16 | — | — | EP | disclosed |
| WO-2007004091-A2 | NOVEL INTERMEDIATES USEFUL FOR THE PREPARATION OF COENZYMES, PROCESS FOR THE PREPARATION OF NOVEL INTERMEDIATES AND AN IMPROVED PROCESS FOR THE PREPARATION OF COENZYMES | NICHOLAS PIRAMAL INDIA LIMITED (IN) | 2007-01-11 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080200732-A1 | Novel Intermediates Useful for the Preparation of Coenzymes, Process for the Preparation of Novel Intermediates and an Improved Process for the Preparation of Coenzymes | NDUFA10, NDUFA9, NDUFB10 | ALDH1A1 536/4885TSHR 4621/4885TDP1 2503/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.